IgA-coated E. Coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation

Science Translational Medicine

Volumn 9, Issue 376, 2017, Pages

  Viladomiu, Monica ^a   Kivolowitz, Charles ^a   Abdulhamid, Ahmed ^a   Dogan, Belgin ^b   Victorio, Daniel ^a   Castellanos, Jim G ^a   Woo, Viola ^a   Teng, Fei ^c   Tran, Nhan L ^c   Sczesnak, Andrew ^d   Chai, Christina ^a   Kim, Myunghoo ^e   Diehl, Gretchen E ^e   Ajami, Nadim J ^e   Petrosino, Joseph F ^e   Zhou, Xi K ^a   Schwartzman, Sergio ^f   Mandl, Lisa A ^f   Abramowitz, Meira ^a   Jacob, Vinita ^a   Bosworth, Brian ^g   Steinlauf, Adam ^a   Scherl, Ellen J ^a   Wu, Hsin Jung Joyce ^c   Simpson, Kenneth W ^b   Longman, Randy S ^a   more..

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d University of California at Berkeley   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f HOSPITAL FOR SPECIAL SURGERY   (United States)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; PROPANEDIOL DEHYDRATASE; RNA 16S; BIOLOGICAL MARKER; DEXTRAN SULFATE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CROHN DISEASE; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FECES MICROFLORA; FEMALE; GNOTOBIOTICS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; MOUSE MODEL; MUCOSAL IMMUNITY; NONHUMAN; PROTEOBACTERIA; RHEUMATOID ARTHRITIS; RNA SEQUENCE; SPONDYLARTHRITIS; TH17 CELL; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; COMPLICATION; EPITHELIUM; IMMUNOLOGY; IMMUNOPHENOTYPING; INFLAMMATION; INTESTINE; ISOLATION AND PURIFICATION; JOINT; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ANIMALS; BIOMARKERS; COLITIS; CROHN DISEASE; DEXTRAN SULFATE; EPITHELIUM; ESCHERICHIA COLI; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOPHENOTYPING; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-23; INTESTINES; JOINTS; MICE, INBRED C57BL; SPONDYLARTHRITIS; TH17 CELLS;

EID: 85012906125     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf9655     Document Type: Article

References (70)

1. E. M. DeFilippis, R. Longman, M. Harbus, K. Dannenberg, E. J. Scherl, Crohn's disease: Evolution, epigenetics, and the emerging role of microbiome-Targeted therapies. Curr. Gastroenterol. Rep. 18, 13 (2016).
2. R. S. Longman, E. J Scherl, in Medical Therapy of Ulcerative Colitis, G. Lichtenstein, Ed. (Springer Science, 2015).
3. R. Peluso, M. N. D. Di Minno, S. Iervolino, F. Manguso, G. Tramontano, P. Ambrosino, C. Esposito, A. Scalera, F. Castiglione, R. Scarpa, Enteropathic spondyloarthritis: From diagnosis to treatment. Clin. Dev. Immunol. 2013, 631408 (2013).
4. J. A. Bargen, Complications and sequelae of chronic ulcerative colitis. Ann. Intern. Med. 3, 335-352 (1929).
5. H. Mielants, E. M. Veys, M. Devos, C. C. Stefan, S. Goemaere, L. Declercq, L. Schatteman, D. Elewaut, The evolution of spondyloarthropathies in relation to gut histology. I. Clinical Aspects. J. Rheumatol. 22, 2266-2272 (1995).
6. L. Van Praet, L. Jans, P. Carron, P. Jacques, E. Glorieus, R. Colman, H. Cypers, H. Mielants, M. De Vos, C. Cuvelier, F. Van den Bosch, D. Elewaut, Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: Results from the GIANT cohort. Ann. Rheum. Dis. 73, 1186-1189 (2014).
7. L. Van Praet, F. E. Van den Bosch, P. Jacques, P. Carron, L. Jans, R. Colman, E. Glorieus, H. Peeters, H. Mielants, M. De Vos, C. Cuvelier, D. Elewaut, Microscopic gut inflammation in axial spondyloarthritis: A multiparametric predictive model. Ann. Rheum. Dis. 72, 414-417 (2013).
8. R. H. Duerr, K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, T. Dassopoulos, A. Bitton, H. Yang, S. Targan, L. W. Datta, E. O. Kistner, L. P. Schumm, A. T. Lee, P. K. Gregersen, M. M. Barmada, J. I. Rotter, D. L. Nicolae, J. H. Cho, A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
9. Wellcome Trust Case Control; Australo-Anglo-American Spondylitis Consortium (TASC), P. R. Burton, D. G. Clayton, L. R. Cardon, N. Craddock, P. Deloukas, A. Duncanson, D. P. Kwiatkowski, M. I. McCarthy, W. H. Ouwehand, N. J. Samani, J. A. Todd, P. Donnelly, J. C. Barrett, D. Davison, D. Easton, D. M. Evans, H. T. Leung, J. L. Marchini, A. P. Morris, C. C. Spencer, M. D. Tobin, A. P. Attwood, J. P. Boorman, B. Cant, U. Everson, J. M. Hussey, J. D. Jolley, A. S. Knight, K. Koch, E. Meech, S. Nutland, C. V. Prowse, H. E. Stevens, N. C. Taylor, G. R. Walters, N. M. Walker, N. A. Watkins, T. Winzer, R. W. Jones, W. L. McArdle, S. M. Ring, D. P. Strachan, M. Pembrey, G. Breen, D. St Clair, S. Caesar, K. Gordon-Smith, L. Jones, C. Fraser, E. K. Green, D. Grozeva, M. L. Hamshere, P. A. Holmans, I. R. Jones, G. Kirov, V. Moskivina, I. Nikolov, M. C. O'Donovan, M. J. Owen, D. A. Collier, A. Elkin, A. Farmer, R. Williamson, P. McGuffin, A. H. Young, I. N. Ferrier, S. G. Ball, A. J. Balmforth, J. H. Barrett, T. D. Bishop, M. M. Iles, et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39, 1329-1337 (2007).
10. D. Gevers, S. Kugathasan, L. A. Denson, Y. Vázquez-Baeza, W. Van Treuren, B. Ren, E. Schwager, D. Knights, S. J. Song, M. Yassour, X. C. Morgan, A. D. Kostic, C. Luo, A. González, D. McDonald, Y. Haberman, T. Walters, S. Baker, J. Rosh, M. Stephens, M. Heyman, J. Markowitz, R. Baldassano, A. Griffiths, F. Sylvester, D. Mack, S. Kim, W. Crandall, J. Hyams, C. Huttenhower, R. Knight, R. J. Xavier, The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392 (2014).
11. J. D. Taurog, R. E. Hammer, Experimental spondyloarthropathy in HLA-B27 transgenic rats. Clin. Rheumatol. 15 (suppl. 1), 22-27 (1996).
12. H. C. Rath, H. H. Herfarth, J. S. Ikeda, W. B. Grenther, T. E. Hamm Jr., E. Balish, J. D. Taurog, R. E. Hammer, K. H. Wilson, R. B. Sartor, Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J. Clin. Invest. 98, 945-953 (1996).
13. P. Cowling, R. Ebringer, D. Cawdell, M. Ishii, A. Ebringer, C-reactive protein, ESR, and klebsiella in ankylosing spondylitis. Ann. Rheum. Dis. 39, 45-49 (1980).
14. P. Cowling, R. Ebringer, A. Ebringer, Association of inflammation with raised serum IgA in ankylosing spondylitis. Ann. Rheum. Dis. 39, 545-549 (1980).
15. M.-E. Costello, F. Ciccia, D. Willner, N. Warrington, P. C. Robinson, B. Gardiner, M. Marshall, T. J. Kenna, G. Triolo, M. A. Brown, Intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol. 2014, 10.1002/art.38967(2014).
16. J. U. Scher, A. Sczesnak, R. S. Longman, N. Segata, C. Ubeda, C. Bielski, T. Rostron, V. Cerundolo, E. G. Pamer, S. B. Abramson, C. Huttenhower, D. R. Littman, Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2, e01202 (2013).
17. X. Zhang, D. Zhang, H. Jia, Q. Feng, D. Wang, D. Liang, X. Wu, J. Li, L. Tang, Y. Li, Z. Lan, B. Chen, Y. Li, H. Zhong, H. Xie, Z. Jie, W. Chen, S. Tang, X. Xu, X. Wang, X. Cai, S. Liu, Y. Xia, J. Li, X. Qiao, J. Y. Al-Aama, H. Chen, L. Wang, Q. J. Wu, F. Zhang, W. Zheng, Y. Li, M. Zhang, G. Luo, W. Xue, L. Xiao, J. Li, W. Chen, X. Xu, Y. Yin, H. Yang, J. Wang, K. Kristiansen, L. Liu, T. Li, Q. Huang, Y. Li, J. Wang, The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21, 895-905 (2015).
18. J. U. Scher, C. Ubeda, A. Artacho, M. Attur, S. Isaac, S. M. Reddy, S. Marmon, A. Neimann, S. Brusca, T. Patel, J. Manasson, E. G. Pamer, D. R. Littman, S. B. Abramson, Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 67, 128-139 (2015).
19. N. W. Palm, M.R. de Zoete, T. W. Cullen, N. A. Barry, J. Stefanowski, L. Hao, P. H. Degnan, J. Hu, I. Peter, W. Zhang, E. Ruggiero, J. H. Cho, A. L. Goodman, R. A. Flavell, Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000-1010 (2014).
20. H.-J. Wu, I. I. Ivanov, J. Darce, K. Hattori, T. Shima, Y. Umesaki, D. R. Littman, C. Benoist, D. Mathis, Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827 (2010).
21. II Ivanov, K. Atarashi, N. Manel, E. L. Brodie, T. Shima, U. Karaoz, D. Wei, K. C. Goldfarb, C. A. Santee, S. V. Lynch, T. Tanoue, A. Imaoka, K. Itoh, K. Takeda, Y. Umesaki, K. Honda, D. R. Littman, Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009).
22. M. Asquith, P. Stauffer, S. Davin, C. Mitchell, M. P. Lin, J. T. Rosenbaum, Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis. Arthritis Rheumatol. 68, 2151-2162 (2016).
23. A. L. Kau, J. D. Planer, J. Liu, S. Rao, T. Yatsunenko, I. Trehan, M. J. Manary, T.-C. Liu, T. S. Stappenbeck, K. M. Maleta, P. Ashorn, K. G. Dewey, E. R. Houpt, C.-S. Hsieh, J. I. Gordon, Functional characterization of IgA-Targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy. Sci. Transl. Med. 7, 276ra224 (2015).
24. L. A. van der Waaij, F. G. Kroese, A. Visser, G. F. Nelis, B. D. Westerveld, P. L. Jansen, J. O. Hunter, Immunoglobulin coating of faecal bacteria in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 16, 669-674 (2004).
25. E. J. Scherl, R. S. Longman, Biomarkers stratify disease phenotype and therapeutic response in inflammatory bowel disease. Eur. Gastroenterol. Hepatol. Rev. 7, 224-228 (2012).
26. I. Mukhopadhya, R. Hansen, E. M. El-Omar, G. L. Hold, IBD-What role do Proteobacteria play? Nat. Rev. Gastroenterol. Hepatol. 9, 219-230 (2012).
27. B. Willing, J. Halfvarson, J. Dicksved, M. Rosenquist, G. Jarnerot, L. Engstrand, C. Tysk, J. K. Jansson, Twin studies reveal specific imbalances in the mucosa-Associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 15, 653-660 (2009).
28. D. N. Frank, A. L. St. Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz, N. R. Pace, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 104, 13780-13785 (2007).
29. N. Rolhion, A. Darfeuille-Michaud, Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm. Bowel Dis. 13, 1277-1283 (2007).
30. M. Baumgart, B. Dogan, M. Rishniw, G. Weitzman, B. Bosworth, R. Yantiss, R. H. Orsi, M. Wiedmann, P. McDonough, S. G. Kim, D. Berg, Y. Schukken, E. Scherl, K. W. Simpson, Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 1, 403-418 (2007).
31. B. Dogan, E. Scherl, B. Bosworth, R. Yantiss, C. Altier, P. L. McDonough, Z. D. Jiang, H. L. Dupont, P. Garneau, J. Harel, M. Rishniw, K. W. Simpson, Multidrug resistance is common in Escherichia coli associated with ileal Crohn's disease. Inflamm. Bowel Dis. 19, 141-150 (2012).
32. S. Miquel, E. Peyretaillade, L. Claret, A. de Vallée, C. Dossat, B. Vacherie, E. Zineb, B. Segurens, V. Barbe, P. Sauvanet, C. Neut, J.-F. Colombel, C. Medigue, F. J. M. Mojica, P. Peyret, R. Bonnet, A. Darfeuille-Michaud, Complete genome sequence of Crohn's disease-Associated adherent-invasive E. coli strain LF82. PLOS ONE 5, 10.1371/journal.pone.0012714(2010).
33. B. Dogan, H. Suzuki, D. Herlekar, R. B. Sartor, B. J. Campbell, C. L. Roberts, K. Stewart, E. J. Scherl, Y. Araz, P. P. Bitar, T. Lefébure, B. Chandler, Y. H. Schukken, M. J. Stanhope, K. W. Simpson, Inflammation-Associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation. Inflamm. Bowel Dis. 20, 1919-1932 (2014).
34. R. S. Longman, Y. Yang, G. E. Diehl, S. V. Kim, D. R. Littman, Microbiota: Host interactions in mucosal homeostasis and systemic autoimmunity. Cold Spring Harb. Symp. Quant. Biol. 78, 193-201 (2013).
35. V. Gaboriau-Routhiau, S. Rakotobe, E. Lécuyer, I. Mulder, A. Lan, C. Bridonneau, V. Rochet, A. Pisi, M. De Paepe, G. Brandi, G. Eberl, J. Snel, D. Kelly, N. Cerf-Bensussan, The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689 (2009).
36. Y. K. Lee, J. S. Menezes, Y. Umesaki, S. K. Mazmanian, Microbes and health sackler colloquium: Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 108 (suppl. 1), 4615-4622 (2010).
37. A. Calin, J. P. Nakache, A. Gueguen, H. Zeidler, H. Mielants, M. Dougados, Defining disease activity in ankylosing spondylitis: Is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 38, 878-882 (1999).
38. M. Rudwaleit, D. van der Heijde, R. Landewe, N. Akkoc, J. Brandt, C. T. Chou, M. Dougados, F. Huang, J. Gu, Y. Kirazli, F. Van den Bosch, I. Olivieri, E. Roussou, S. Scarpato, I. J. Sørensen, R. Valle-Oñate, U. Weber, J. Wei, J. Sieper, The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann. Rheum. Dis. 70, 25-31 (2011).
39. J. J. Bunker, T. M. Flynn, J. C. Koval, D. G. Shaw, M. Meisel, B. D. McDonald, I. E. Ishizuka, A. L. Dent, P. C. Wilson, B. Jabri, D. A. Antonopoulos, A. Bendelac, Innate and adaptive humoral responses coat distinct commensal bacteria with immunoglobulin Immunity 43, 541-553 (2015).
40. E. Sefik, N. Geva-Zatorsky, S. Oh, L. Konnikova, D. Zemmour, A. M. McGuire, D. Burzyn, A. Ortiz-Lopez, M. Lobera, J. Yang, S. Ghosh, A. Earl, S. B. Snapper, R. Jupp, D. Kasper, D. Mathis, C. Benoist, MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORg+ regulatory T cells. Science 349, 993-997 (2015).
41. G. F. Sonnenberg, D. Artis, Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat. Med. 21, 698-708 (2015).
42. K. Atarashi, T. Tanoue, M. Ando, N. Kamada, Y. Nagano, S. Narushima, W. Suda, A. Imaoka, H. Setoyama, T. Nagamori, E. Ishikawa, T. Shima, T. Hara, S. Kado, T. Jinnohara, H. Ohno, T. Kondo, K. Toyooka, E. Watanabe, S.-i. Yokoyama, S. Tokoro, H. Mori, Y. Noguchi, H. Morita, I. I. Ivanov, T. Sugiyama, G. Nuñez, J. G. Camp, M. Hattori, Y. Umesaki, K. Honda, Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163, 367-380 (2015).
43. T. Sano, W. Huang, J. A. Hall, Y. Yang, A. Chen, S. J. Gavzy, J.-Y. Lee, J. W. Ziel, E. R. Miraldi, A. I. Domingos, R. Bonneau, D. R. Littman, An IL-23R/IL-22 circuit regulates epithelial serum amyloid a to promote local effector Th17 responses. Cell 163, 381-393 (2015).
44. C. Vignaroli, L. Di Sante, G. Magi, G. M. Luna, A. Di Cesare, S. Pasquaroli, B. Facinelli, F. Biavasco, Adhesion of marine cryptic Escherichia isolates to human intestinal epithelial cells. ISME J. 9, 508-515 (2015).
45. T. C. Fung, N. J. Bessman, M. R. Hepworth, N. Kumar, N. Shibata, D. Kobuley, K. Wang, C. G. Ziegler, J. Goc, T. Shima, Y. Umesaki, R. B. Sartor, K. V. Sullivan, T. D. Lawley, J. Kunisawa, H. Kiyono, G. F. Sonnenberg, Lymphoid-Tissue-resident commensal bacteria promote members of the IL-10 cytokine family to establish mutualism. Immunity 44, 634-646 (2016).
46. C. S. Eun, Y. Mishima, S. Wohlgemuth, B. Liu, M. Bower, I. M. Carroll, R. B. Sartor, Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-/- mice. Infect. Immun. 82, 2239-2246 (2014).
47. J. H. Cox, N. M. Kljavin, N. Ota, J. Leonard, M. Roose-Girma, L. Diehl, W. Ouyang, N. Ghilardi, Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice. Mucosal Immunol. 5, 99-109 (2012).
48. F. Zorzi, I. Monteleone, M. Sarra, E. Calabrese, I. Marafini, M. Cretella, S. Sedda, L. Biancone, F. Pallone, G. Monteleone, Distinct profiles of effector cytokines mark the different phases of Crohn's disease. Plos One 8, e54562 (2013).
49. J. Li, A. Ueno, M. Fort Gasia, J. Luider, T. Wang, C. Hirota, H. B. Jijon, M. Deane, M. Tom, R. Chan, H. W. Barkema, P. L. Beck, G. G. Kaplan, R. Panaccione, J. Qian, M. Iacucci, X. Gui, S. Ghosh, Profiles of lamina propria T helper cell subsets discriminate between ulcerative colitis and Crohn's disease. Inflamm. Bowel Dis. 22, 1779-1792 (2016).
50. E. Slack, S. Hapfelmeier, B. Stecher, Y. Velykoredko, M. Stoel, M. A. E. Lawson, M. B. Geuking, B. Beutler, T. F. Tedder, W.-D. Hardt, P. Bercik, E. F. Verdu, K. D. McCoy, A. J. Macpherson, Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325, 617-620 (2009).
51. T. G. Tan, E. Sefik, N. Geva-Zatorsky, L. Kua, D. Naskar, F. Teng, L. Pasman, A. Ortiz-Lopez, R. Jupp, H. J. Wu, D. L. Kasper, C. Benoist, D. Mathis, Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc. Natl. Acad. Sci. U.S.A. 113, E8141-E8150 (2016).
52. M. Derrien, C. Belzer, W. M. de Vos, Akkermansia muciniphila and its role in regulating host functions. Microb. Pathog. 2016, 10.1016/j.micpath.2016.02.005(2016).
53. M. Yassour, M. Y. Lim, H. S. Yun, T. L. Tickle, J. Sung, Y.-M. Song, K. Lee, E. A. Franzosa, X. C. Morgan, D. Gevers, E. S. Lander, R. J. Xavier, B. W. Birren, G. Ko, C. Huttenhower, Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med. 8, 17 (2016).
54. F. Ciccia, M. Bombardieri, A. Principato, A. Giardina, C. Tripodo, R. Porcasi, S. Peralta, V. Franco, E. Giardina, A. Craxi, C. Pitzalis, G. Triolo, Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum. 60, 955-965 (2009).
55. P. Lin, M. Bach, M. Asquith, A. Y. Lee, L. Akileswaran, P. Stauffer, S. Davin, Y. Pan, E. D. Cambronne, M. Dorris, J. W. Debelius, C. L. Lauber, G. Ackermann, Y. V. Baeza, T. Gill, R. Knight, R. A. Colbert, J. D. Taurog, R. N. Van Gelder, J. T. Rosenbaum, HLA-B27 and human b2-microglobulin affect the gut microbiota of transgenic rats. PLOS ONE 9, e105684 (2014).
56. T. Rashid, A. Ebringer, Autoimmunity in rheumatic diseases is induced by microbial infections via crossreactivity or molecular mimicry. Autoimmune Dis. 2012, 539282 (2012).
57. F. Ciccia, G. Guggino, A. Rizzo, L. Saieva, S. Peralta, A. Giardina, A. Cannizzaro, G. Sireci, G. De Leo, R. Alessandro, G. Triolo, Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann. Rheum. Dis. 74, 1739-1747 (2015).
58. D. O. Clegg, D. J. Reda, M. H. Weisman, W. D. Blackburn, J. J. Cush, G. W. Cannon, M. L. Mahowald, H. R. Schumacher Jr., T. Taylor, E. Budiman-Mak, M. R. Cohen, F. B. Vasey, M. E. Luggen, E. Mejias, S. L. Silverman, R. Makkena, F. P. Alepa, J. Buxbaum, C. M. Haakenson, R. H. Ward, B. J. Manaster, R. J. Anderson, J. R. Ward, W. G. Henderson, Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum. 39, 2004-2012 (1996).
59. S. Generini, R. Giacomelli, R. Fedi, A. Fulminis, A. Pignone, G. Frieri, A. Del Rosso, A. Viscido, B. Galletti, M. Fazzi, F. Tonelli, M. Matucci-Cerinic, Infliximab in spondyloarthropathy associated with Crohn's disease: An open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations. Ann. Rheum. Dis. 63, 1664-1669 (2004).
60. W. Hueber, B. E. Sands, S. Lewitzky, M. Vandemeulebroecke, W. Reinisch, P. D. Higgins, J. Wehkamp, B. G. Feagan, M. D. Yao, M. Karczewski, J. Karczewski, N. Pezous, S. Bek, G. Bruin, B. Mellgard, C. Berger, M. Londei, A. P. Bertolino, G. Tougas, S. P. Travis; Secukinumab in Crohn's Disease Study Group, Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: Unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61, 1693-1700 (2012).
61. J. Braun, R. van den Berg, X. Baraliakos, H. Boehm, R. Burgos-Vargas, E. Collantes-Estevez, H. Dagfinrud, B. Dijkmans, M. Dougados, P. Emery, P. Geher, M. Hammoudeh, R. D. Inman, M. Jongkees, M. A. Khan, U. Kiltz, T. Kvien, M. Leirisalo-Repo, W. P. Maksymowych, I. Olivieri, K. Pavelka, J. Sieper, E. Stanislawska-Biernat, D. Wendling, S. Özgocmen, C. van Drogen, B. van Royen, D. van der Heijde, 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann. Rheum. Dis. 70, 896-904 (2011).
62. P. J. McMurdie, S. Holmes, phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLOS ONE 8, e61217 (2013).
63. Human Microbiome Project Consortium, Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214 (2012).
64. C.-S. Chin, D. H. Alexander, P. Marks, A. A. Klammer, J. Drake, C. Heiner, A. Clum, A. Copeland, J. Huddleston, E. E. Eichler, S. W. Turner, J. Korlach, Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat. Methods 10, 563-569 (2013).
65. R. K. Aziz, D. Bartels, A. A. Best, M. DeJongh, T. Disz, R. A. Edwards, K. Formsma, S. Gerdes, E. M. Glass, M. Kubal, F. Meyer, G. J. Olsen, R. Olson, A. L. Osterman, R. A. Overbeek, L. K. McNeil, D. Paarmann, T. Paczian, B. Parrello, G. D. Pusch, C. Reich, R. Stevens, O. Vassieva, V. Vonstein, A. Wilke, O. Zagnitko, The RAST Server: Rapid annotations using subsystems technology. BMC Genomics 9, 75 (2008).
66. A. L. Delcher, K. A. Bratke, E. C. Powers, S. L. Salzberg, Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 23, 673-679 (2007).
67. I. Grin, D. Linke, GCView: The genomic context viewer for protein homology searches. Nucleic Acids Res. 39, W353-W356 (2011).
68. U. Erben, C. Loddenkemper, K. Doerfel, S. Spieckermann, D. Haller, M. M. Heimesaat, M. Zeitz, B. Siegmund, A. A. Kühl, A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int. J. Clin. Exp. Pathol. 7, 4557-4576 (2014).
69. G. E. Diehl, R. S. Longman, J.-X. Zhang, B. Breart, C. Galan, A. Cuesta, S. R. Schwab, D. R. Littman, Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX3CR1hi cells. Nature 494, 116-120 (2013).
70. F. Teng, C. N. Klinger, K. M. Felix, C. P. Bradley, E. Wu, N. L. Tran, Y. Umesaki, H.-J. J. Wu, Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer's patch T follicular helper cells. Immunity 44, 875-888 (2016).